Taro Corporate
Taro U.S.A
Taro Canada
Taro Israel
Sun Pharma
Chattem Chemicals Inc.
Taro RX product details
Taro-Dipyridamole / ASA
Product Information
-
DIN:02471051
-
Active Ingredients :dipyridamole / acetylsalicylic acid
-
Innovator Name:Aggrenox®
-
Category:Antiplatelet Agent
-
Dosage form:Capsule
-
Strength:200 mg / 25 mg
-
Route of Administration:Oral
-
Colour:red/ivory
-
Markings:"927" in black ink
- Package size:
60 Bottle - UPC Code:
063691082953 -
Description :Size "00", red/ivory opaque capsule shell imprinted with "927" on cap and body in black ink
-
Non-medicinal ingredients :Acacia, Colloidal Silicon Dioxide, Ethyl Cellulose, Hypromellose phthalate, Hypromellose, Methacrylic acid copolymer type B, Microcrystalline Cellulose, Starch, Stearic acid, Talc, Tartaric acid, Titanium Dioxide, Triacetin, and Triethyl citrate. The capsule shell contains: gelatine, Sodium Lauryl Sulphate, Titanium dioxide, Iron Oxide Red, Iron Oxide Yellow, Water and Imprinting ink (TEK print SW-9008 Black Ink)
All brand names and trademarks referenced remain the property of their respective owners.
To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.
For Provincial Formulary Status click here